End of dose interval symptoms in patients treated with...

  • Main
  • 2020 / 2
  • End of dose interval symptoms in patients treated with...

End of dose interval symptoms in patients treated with natalizumab: a role for serum cytokines?

Cathérine, Dekeyser, Annelien, De Pue, Anne, Sieben, Luc, Algoed, Liesbeth, Van Hijfte, Gerlo, Sarah, Guy, Laureys
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2020.102020
Date:
February, 2020
File:
PDF, 808 KB
english, 2020
Conversion to is in progress
Conversion to is failed